Heterobimetallic bismuth-transition metal salicylate complexes as molecular precursors for ferroelectric materials. Synthesis and structure of Bi(2)M(2)(sal)(4)(Hsal)(4)(OR) (4) (M = Nb,Ta; R = CH(2)CH(3), CH(CH(3))(2)), Bi(2)Ti(3)(sal)(8)(Hsal)(2), and Bi(2)Ti(4)(O(i)Pr)(sal)(10)(Hsal) (sal = O(2)CC(6)H(4)-2-O; Hsal = O(2)CC(6)H(4)-2-OH)

The reactions between triphenylbismuth, salicylic acid, and the metal alkoxides M(OCH(2)CH(3))(5) (M = Nb, Ta) or Ti[OCH(CH(3))(2)](4) have been investigated under different reaction conditions and in different stoichiometries. Six novel heterobimetallic bismuth alkoxy-carboxylate complexes have been synthesized in good yield as crystalline solids. These include Bi(2)M(2)(sal)(4)(Hsal)(4)(OR)(4) (M = Nb, Ta; R = CH(2)CH(3), CH(CH(3))(2)), Bi(2)Ti(3)(sal)(8)(Hsal)(2), and Bi(2)Ti(4)(O(i)Pr)(sal)(10)(Hsal) (sal = O(2)CC(6)H(4)-2-O; Hsal = O(2)CC(6)H(4)-2-OH). The complexes have been characterized spectroscopically and by single-crystal X-ray diffraction. Compounds of the group V transition metals contain metal ratios appropriate for precursors of ferroelectric materials. The molecules exhibit excellent solubility in common organic solvents and good stability against unwanted hydrolysis. The nature of the thermal decomposition of the complexes has been explored by thermogravimetric analysis and powder X-ray diffraction. We have shown that the complexes are converted to the corresponding oxide by heating in an oxygen atmosphere at 500 degrees C. The mass loss of the complexes, as indicated by thermogravimetric analysis, and the resulting unit cell parameters of the oxides are consistent with the formation of the desired heterobimetallic oxide. The complexes decomposed to form the bismuth-rich phases Bi(4)Ti(3)O(12) and Bi(5)Nb(3)O(15) as well as the expected oxides BiMO(4) (M = Nb, Ta) and Bi(2)Ti(4)O(11).     

Bias of cartilage T2 values related to method of calculation

Purpose

To determine how different methods for calculating T₂ affect the resulting T₂ values of patellar cartilage.

Materials and Methods

T₂-weighted images of patellar cartilage for 10 subjects were acquired using two MRI scanners. T₂ values of patellar cartilage were calculated using linear, weighted and nonlinear fitting algorithms for a monoexponential decay equation. T₂ values were also calculated for the superficial, middle and deep zones of the cartilage.

Results

All three methods of calculation resulted in significantly different T₂ values (P<.0001). The weighted calculation produced the highest T₂ values, and the nonlinear calculation produced the lowest T₂ values. The average difference of T₂ value between the methods was under 5 ms. Similar results were found in a zonal analysis of the tissue. The nonlinear calculation of T₂ consistently had the best fit to the acquired data.

Conclusion

The T₂ value of patellar cartilage depends on the method of calculation. It is unclear if larger T₂ value differences would be seen in subjects diagnosed with osteoarthritis. This study highlights the potential difficulty of comparing different studies with one another based on the method of T₂ calculation.     

Mechanism of alkane transfer-dehydrogenation catalyzed by a pincer-ligated iridium complex

The mechanism of (PCP)Ir-catalyzed transfer-dehydrogenation has been elucidated for the prototypical substrate/acceptor couple, COA/TBE, at 55 degrees C (COA = cyclooctane; TBE = tert-butylethylene). The catalytic cycle may be viewed as the sum of two reactions: (i) hydrogenation of TBE by (PCP)IrH2 and C-H addition of a second mole of TBE to give (PCP)IrH(tert-butylvinyl), and (ii) dehydrogenation of COA by (PCP)IrH(tert-butylvinyl) to give (PCP)IrH2, COE, and TBE. These two stoichiometric reactions have been observed independently and their kinetics determined. The overall catalysis has also been monitored in situ, and (PCP)IrH2 and (PCP)IrH(tert-butylvinyl) have been observed as the resting states; the ratio of these two complexes is found to be proportional to [TBE]2. Based upon the proportionality constant thus obtained and the catalytic rate as a function of [TBE] (which reaches a maximum at ca. 0.3 M), the respective rate constants for the hydrogenation and dehydrogenation segments can be obtained. Good agreement is found between the rates independently obtained from stoichiometric and catalytic runs. Within the overall TBE-hydrogenation reaction, labeling experiments indicate that the rate-determining step is the reductive elimination of TBA (2,2-dimethylbutane) from (PCP)IrH(tert-butylethyl) (which is formed via insertion of TBE into an Ir-H bond of (PCP)IrH2). Based upon considerations of microscopic reversibility, it can be further inferred that the rate-determining step for the alkane dehydrogenations is C-H addition (and not beta-H elimination).     

Synthesis characterization and X-ray crystal structures of cis-1,4-diaminocyclohexane-platinum(II) nucleobase adducts

Platinum complexes of the type [Pt(cis-1,4-DACH)(L)₂]X, where cis-1,4-DACH = cis-1,4-diaminocyclohexane; L = adenine (ade) (1), hypoxanthine (hyp) (2), 9-methylguanine (9-megua) (3), cytosine (cyt) (4), or 1-methylcytosine (1-mecyt) (5); and X = SO₄ or Cl₂ groups, were synthesized and characterized by elemental analysis and by ¹H, ¹³C, and ¹⁹⁵Pt nuclear magnetic resonance spectroscopy. The crystals of [Pt(cis-1,4-DACH)(9-megua)₂]SO₄[9-megua-H]₂SO₄ (3) and [Pt(cis-1,4-DACH)(1-mecyt)₂]Cl₂ · 6H₂O (5) were also subjected to single-crystal X-ray diffraction. The base/PtN4 coordination plane dihedral angles were 74.55° and 85.61° in complex 3 and 78.12° and 81.80° in complex 5. The platinum had distorted square planar geometry in both complexes; the two adjacent corners were occupied by the two nitrogen atoms of cis-1,4-DACH, and the other two corners were occupied by the two N7 atoms of 9-megua in complex 3 and the two N3 atoms of 1-mecyt in complex 5. The cis-1,4-DACH, which has a unique twist-boat configuration, formed a seven-member chelating ring with platinum, which led to considerable strain during bidentate cis-1,4-DACH binding. Cations of both complexes 3 and 5 adopted C₂ molecular symmetry. These adducts were the models for the intrastand cross-links that were relevant to the binding of the Pt(II) antitumor drugs to DNA.